Khon Kaen University

Researchers

• WLWatcharin Loilome

Running trials

• Not yet recruiting

  An AI-Based Erythema Measurement System for Psoriasis Lesions

  NCT07494396· Khon Kaen University· Source

• Not yet recruiting

  Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II

  NCT07513623· Phase 2· University of California, San Francisco· Source

• Recruiting

  Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

  NCT07245238· Phase 3· Khon Kaen University· Source

• Recruiting

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  NCT06952504· Phase 3· Merck Sharp & Dohme LLC· Source

• Enrolling by invitation

  Efficacy of Topical Cannabidiol for Eczema

  NCT06994520· Phase 2· Khon Kaen University· Source

• Recruiting

  Postoperative Atrial Fibrillation in Cardiac Surgery

  NCT06958029· Khon Kaen University· Source

• Recruiting

  A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  NCT06841354· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

  NCT06337032· Phase 4· Gilead Sciences· Source

• Recruiting

  Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand

  NCT05321992· McMaster University· Source

• Recruiting

  COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2

  NCT06396299· Mahidol University· Source

• Active, not recruiting

  A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

  NCT06097364· Phase 3· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

  NCT06074588· Phase 3· Merck Sharp & Dohme LLC· Source

• Enrolling by invitation

  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

  NCT05979441· Phase 3· argenx· Source

• Recruiting

  A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

  NCT05744921· Phase 3· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

  NCT05462717· Phase 1· Revolution Medicines, Inc.· Source

• Active, not recruiting

  LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321420· Phase 2· PureTech· Source

• Active, not recruiting

  Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

  NCT05248646· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Recruiting

  Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

  NCT04375800· Phase 2· Merck Sharp & Dohme LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Cytomegalovirus infection1 recruiting
• Dermatomyositis and polymyositis (myositis)1 recruiting
• Endometrial cancer1 recruiting
• HIV1 recruiting
• Liver and biliary tract cancer1 recruiting
• Psoriasis1 recruiting
• Stroke1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Completed

  Self-management Telehealth Program for Scleroderma

  NCT06990386· Khon Kaen University· Source

• Completed

  Effectiveness of Cannabinoids on Appetite in Scleroderma

  NCT05416697· Phase 3· Khon Kaen University· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· Phase 2/3· argenx· Source

• Completed

  A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

  NCT05133531· Phase 3· Regeneron Pharmaceuticals· Source

• Completed

  Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children

  NCT01854775· Phase 2/3· Gilead Sciences· Source

• Completed

  A Prospective Cohort of Children With HIV Infection

  NCT00476606· The HIV Netherlands Australia Thailand Research Collaboration· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Liver and biliary tract cancer91 works · 1 trial
• Thalassaemia19 works · 0 trials
• Systemic sclerosis (scleroderma)19 works · 3 trials
• Meningioma7 works · 0 trials